Fonte: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FFCLRP
Assuntos: ELETROFORESE (MÉTODO DE SEPARAÇÃO), METABOLISMO, ENZIMAS, DOENÇAS GENÉTICAS, FÁRMACOS
ABNT
BOCATO, Mariana Zuccherato et al. In vitro enantioselective human liver microsomal metabolism and prediction of in vivo pharmacokinetic parameters of tetrabenazine by DLLME-CE. Journal of Pharmaceutical and Biomedical Analysis, v. 128, p. 528-537, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2016.06.028. Acesso em: 25 set. 2024.APA
Bocato, M. Z., Moreira, F. de L., Albuquerque, N. C. P. de, Gaitani, C. M. de, & Oliveira, A. R. M. de. (2016). In vitro enantioselective human liver microsomal metabolism and prediction of in vivo pharmacokinetic parameters of tetrabenazine by DLLME-CE. Journal of Pharmaceutical and Biomedical Analysis, 128, 528-537. doi:10.1016/j.jpba.2016.06.028NLM
Bocato MZ, Moreira F de L, Albuquerque NCP de, Gaitani CM de, Oliveira ARM de. In vitro enantioselective human liver microsomal metabolism and prediction of in vivo pharmacokinetic parameters of tetrabenazine by DLLME-CE [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2016 ; 128 528-537.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.jpba.2016.06.028Vancouver
Bocato MZ, Moreira F de L, Albuquerque NCP de, Gaitani CM de, Oliveira ARM de. In vitro enantioselective human liver microsomal metabolism and prediction of in vivo pharmacokinetic parameters of tetrabenazine by DLLME-CE [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2016 ; 128 528-537.[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.jpba.2016.06.028